A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer
Clinical trial NCT02231723 · COMPLETED
Trial details
- NCT number
- NCT02231723
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2020-06-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.